Forecast & Rating10 analysts currently cover enGene Therapeutics, with about 30.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $3.29, about 81.5% upside from the current price of $1.81. Price targets range from $2.00 to $5.00 — a wide spread, showing clear disagreement over just how much enGene Therapeutics can rise. For you, this means most institutions are cautious on enGene Therapeutics's outlook. Data as of Aug 12, 2026; for reference only and not investment advice.
Aug 12, 2026Price forecast
$3.2981.53%
Forecast & RatingHold
10analysts
- Strong buy20.00%
- Buy10.00%
- Hold60.00%
- Sell10.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met0.0%
Stock price$1.81
Avg. target$3.3
High target$5
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.